Identifying chronic obstructive pulmonary disease in primary care of urban underserved patients: Tools, applications, and challenges

Journal of the National Medical Association

Volumn 102, Issue 7, 2010, Pages 570-578

  Duvall, Karen ^a   Frank, Gerard W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

COPD; Lungs; Race ethnicity; Socioeconomic status

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; INFLUENZA; PATIENT IDENTIFICATION; PNEUMONIA; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SMOKING CESSATION; SPIROMETRY; URBAN POPULATION; VACCINATION; HEALTH CARE PLANNING; HEALTH DISPARITY; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

HEALTH STATUS DISPARITIES; HUMANS; MEDICALLY UNDERSERVED AREA; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; URBAN POPULATION;

EID: 77956838413     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)30623-4     Document Type: Review

References (75)

1. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA. 2005;294:1255-1259.
2. Deaths from chronic obstructive pulmonary disease - United States, 2000-2005. MMWR Morb Mortal Wkly Rep. 2008;57:1229-1232.
3. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of COPD. www.goldcopd.org. Accessed December 2, 2008.
4. Morbidity and Mortality: 2007 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: National Heart, Lung, and Blood Institute, US Department of Health and Human Services; 2007.
5. Foster TS, Miller JD, Morton JP, Caloyeras JP, Russell MW, Menzin J. Assessment of the economic burden of COPD in the United States: a review and synthesis of the literature. COPD. 2006;3:211-218. (Pubitemid 44949061)
6. Barr RG, Celli BR, Martinez FJ, et al. Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey [abstract]. Am J Med. 2005;118:1415.
7. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932-946. (Pubitemid 38807371)
8. O'Donnell DE, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J. 2008;15(supplA):1A-8A.
9. Cooper CB, Dransfield M. Primary care of the patient with chronic obstructive pulmonary disease-part 4: understanding the clinical manifestations of a progressive disease. Am J Med. 2008;121(7)(suppl 1):S33-S45. (Pubitemid 351847619)
10. Alexopoulos EC, Burdorf A. Prognostic factors for respiratory sickness absence and return to work among blue collar workers and office personnel. Occup Environ Med. 2001;58:246-252. (Pubitemid 32240978)
11. Isoaho R, Puolijoki H, Huhti E, Laippala P, Kivela SL. Chronic obstructive pulmonary disease and self-maintaining functions in the elderly - a population-based study. Scand J Prim Health Care. 1995;13:122-127.
12. Jacobs JE, Maille AR, Akkermans RP, van Weel C, Grol RP. Assessing the quality of life of adults with chronic respiratory diseases in routine primary care: construction and first validation of the 10-item Respiratory Illness Questionnaire-monitoring 10 (RIQ-MON10). Qual Life Res. 2004;13:1117-1127.
13. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ. 1977;1:1645-1648. (Pubitemid 8124466)
14. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:1608-1613. (Pubitemid 30329036)
15. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crif Care Med. 2005;171:972-977. (Pubitemid 40616945)
16. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847-852. (Pubitemid 35178607)
17. Zoia MC, Corsico AG, Beccaria M, et al. Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management. Respir Med. 2005;99:1568-1575. (Pubitemid 41683937)
18. Mandelberg JH, Kuhn RE, Kohn MA. Epidemiologic analysis of an urban, public emergency department's frequent users. Acad Emerg Med. 2000;7:637-646.
19. Tsai CL, Clark S, Cydulka RK, Rowe BH, Camargo CA, Jr. Factors associated with hospital admission among emergency department patients with chronic obstructive pulmonary disease exacerbation. Acad Emerg Med. 2007;14:6-14.
20. Wilper AP, Woolhandler S, Lasser KE, McCormick D, Bor DH, Himmelstein DU. A national study of chronic disease prevalence and access to care in uninsured US adults. Ann Intern Med. 2008;149:170-176.
21. Bindman AB, Chattopadhyay A, Auerback GM. Interruptions in Medicaid coverage and risk for hospitalization for ambulatory care-sensitive conditions. Ann Intern Med. 2008;149:854-860.
22. Akazawa M, Halpern R, Riedel AA, Stanford RH, Dalal A, Blanchette CM. Economic burden prior to COPD diagnosis: a matched case-control study in the United States. Respir Med. 2008;102:1744-1752.
23. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:925-931. (Pubitemid 41598207)
24. McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest. 2007;132:1748-1755.
25. Zielinski J, MacNee W, Wedzicha J, et al. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch Chest Dis. 1997;52:43-47. (Pubitemid 27232210)
26. Dransfield MT, Bailey WC. COPD: racial disparities in susceptibility, treatment, and outcomes. Clin Chesf Med. 2006;27:463-471, vii.
27. Moser JW, Langwell K. Differences by race/ethnicity in smoking behavior and smoking cessation of the Medicare population, Baltimore, MD: Centers for Medicare and Medicaid Services; 2002.
28. Walters JA, Hansen EC, Walters EH, Wood-Baker R. Under-diagnosis of chronic obstructive pulmonary disease: a qualitative study in primary care. Respir Med. 2008;102:738-743.
29. Kaminsky DA, Marcy TW, Bachand M, Irvin CG. Knowledge and use of office spirometry for the detection of chronic obstructive pulmonary disease by primary care physicians. Respir Care. 2005;50:1639-1648. (Pubitemid 46888423)
30. Derom E, van Weel C, Liistro G, et al. Primary care spirometry. Eur Respir J. 2008;31:197-203.
31. Petty TL, Mannino DM. Will recommendations against spirometry make chronic obstructive pulmonary disease harder to treat? Ann Intern Med. 2008;149:512-513; author reply 513.
32. Luo Z, Alvarado GF, Hatsukami DK, et al. Race differences in nicotine dependence in the Collaborative Genetic Study of Nicotine Dependence (COGEND). Nicotine Tob Res. 2008;10:1223-1230.
33. Laditka JN, Laditka SB. Race, ethnicity and hospitalization for six chronic ambulatory care sensitive conditions in the USA. Ethn Health. 2006;11:247-263.
34. Lipton R, Banerjee A. The geography of chronic obstructive pulmonary disease across time: California in 1993 and 1999. Int J Med Sci. 2007;4:179-189.
35. Enright PL, Arnold A, Manolio TA, Kuller LH. Spirometry reference values for healthy elderly blacks. The Cardiovascular Health Study Research Group. Chest. 1996;110:1416-1424.
36. Hegewald MJ, Crapo RO. Socioeconomic status and lung function. Chest. 2007;132:1608-1614.
37. Sood A, Stidley CA, Picchi MA, et al. Difference in airflow obstruction between Hispanic and non-Hispanic White female smokers. COPD. 2008;5:274-281.
38. Smith GD, Neaton JD, Wentworth D, Stamler R, Stamler J. Socioeconomic differentials in mortality risk among men screened for the Multiple Risk Factor Intervention Trial: I. White men. Am J Public Health. 1996;86:486-496. (Pubitemid 26125027)
39. Smith GD, Wentworth D, Neaton JD, Stamler R, Stamler J. Socioeconomic differentials in mortality risk among men screened for the Multiple Risk Factor Intervention Trial: II. Black men. Am J Public Health. 1996;86:497-504. (Pubitemid 26125028)
40. Key Themes and Highlights From the National Healthcare Disparities Report. Agency for Healthcare Research and Quality, US Department of Health and Human Services; 2007. www.ahrq.gov/qual/nhdr06/highlights/nhdr06high.htm. Accessed January 21, 2010.
41. Wouters EF. Economic analysis of the Confronting COPD survey: an overview of results. Respir Med. 2003;97(suppl C):S3-S14.
42. Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA. 2003;290:2301-2312.
43. Casaburi R, Mahler DA, Jones PW, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J. 2002;19:217-224.
44. Spencer S, Calverley PM, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J. 2004;23:698-702.
45. Calverley PM, Nordyke RJ, Halbert RJ, Isonaka S, Nonikov D. Development of a population-based screening questionnaire for COPD. COPD. 2005;2:225-232.
46. Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma. 2006;43:75-80.
47. Screening for chronic obstructive pulmonary disease using spirometry: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;148:529-534.
48. Qaseem A, Snow V, Shekelle P, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007;147:633-638. (Pubitemid 351664484)
49. Enright P, Quanjer P. Spirometry for COPD is both underutilized and overutilized. Chest. 2007;132:368-370.
50. Arnold R, Ranchor AV, Koeter GH, de Jongste MJ, Sanderman R. Consequences of chronic obstructive pulmonary disease and chronic heart failure: the relationship between objective and subjective health. Soc Sci Med. 2005;61:2144-2154. (Pubitemid 41262507)
51. 51: Van Schayck CP, Loozen JM, Wagena E, Akkermans RP, Wesseling GJ. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ. 2002;324:1370.
52. Enright PL. Are six seconds long enough? Prim Care Respir J. 2006;15:268-270.
53. Perez-Padilla R, Vollmer WM, Vazquez-Garcia JC, Enright PL, Menezes AM, Buist AS. Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease? Int J Tuberc Lung Dis. 2009;13:387-393.
54. Chan-Yeung M, Carlsten C. Reasonable alternatives to spirometry for diagnosing chronic obstructive pulmonary disease: is the peak flow meter the answer? Inf J Tuberc Lung Dis. 2009;13:279-280.
55. Kelly CA, Gibson GJ. Relation between FEV1 and peak expiratory flow in patients with chronic airflow obstruction. Thorax. 1988;43:335-336.
56. Enright P. Provide GPs with spirometry, not spirometers. Thorax. 2008;63:387-388.
57. Martinez FJ, Raczek AE, Seifer FD, et al. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD. 2008;5:85-95.
58. Mullerova H, Wedzicha J, Soriano JB, Vestbo J. Validation of a chronic obstructive pulmonary disease screening questionnaire for population surveys. Respir Med. 2004;98:78-83.
59. Price DB, Tinkelman DG, Halbert RJ, et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration. 2006;73:285-295.
60. Tinkelman DG, Price DB, Nordyke RJ, et al. Symptom-based questionnaire for differentiating COPD and asthma. Respiration. 2006;73:296-305.
61. Yawn BP, Mapel DW, Mannino DM, Martinez FJ, Dalal AA. Performance of a brief, self-administered questionnaire (Lung Function Questionnaire) to identify patients at risk of airflow obstruction as potential candidates for spirometry: scoring and cut point [ATS abstract). Am J Respir Crit Care Med. 2009;179:A1476.
62. Dalal AA, Hanania NA, Mintz M, Yawn BP, Mannino DM, Donohue JF. Validation of the Lung Function Questionnaire: a screening tool to identify airflow obstruction [ATS abstract]. Am J Respir Crit Care Med. 2009;179:A1477.
63. Schermer T, Eaton T, Pauwels R, van Weel C. Spirometry in primary care: is it good enough to face demands like World COPD Day? Eur Respir J. 2003;22:725-727.
64. Gorecka D, Bednarek M, Nowinski A, Puscinska E, Goljan-Geremek A, Zielinski J. Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate. Chest. 2003;123:1916-1923.
65. Enright P. Does screening for COPD by primary care physicians have the potential to cause more harm than good? Chest. 2006;129:833-835.
66. Castillo D, Guayta R, Giner J, et al. COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study. Respir Med. 2009;103:839-845.
67. Walters JA, Hansen EC, Johns DP, Blizzard EL, Walters EH, Wood-Baker R. A mixed methods study to compare models of spirometry delivery in primary care for patients at risk of COPD. Thorax. 2008;63:408-414.
68. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med. 2002;166:675-679.
69. Bednarek M, Gorecka D, Wielgomas J, et al. Smokers with airway obstruction are more likely to quit smoking. Thorax. 2006;61:869-873.
70. Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ. 2008;336:598-600.
71. Lin KW. Lung age: Study's conclusion about screening is unwarranted. BMJ. 2008;336:1034.
72. Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008;63:1046-1051.
73. Schermer TR, Quanjer PH. COPD screening in primary care: who is sick? Prim Care Respir J. 2007;16:49-53.
74. Egede LE, Zheng D. Racial/ethnic differences in influenza vaccination coverage in high-risk adults. Am J Public Health. 2003;93:2074-2078.
75. Halpern MT, Stanford RH, Borker R. The burden of COPD in the USA: results from the Confronting COPD survey. Respir Med. 2003;97(suppl C):S81-89.